|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 801 Pennsylvania Ave., NW Suite 745 |
Address2 |
|
| City | WASHINGTON |
State | DC |
Zip Code | 20004 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 5632-12
|
||||||||
|
6. House ID# 312570000
|
||||||||
| TYPE OF REPORT | 8. Year | 2015 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Brian McCullough |
Date | 10/21/2015 3:46:38 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code AGR
16. Specific lobbying issues
Monitor legislative and administrative action related to pollinator health and habitat promotion.
Monitor legislative and administrative action related to pesticide registration.
Monitor legislative and administrative action related to biotechnology deregulation.
Monitor legislative and administrative action related to genetically modified labeling.
S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling.
S. 621, Preventing Antibiotic Resistance Act of 2015.
H.R. 897, Reducing Regulatory Burdens Act of 2015.
H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling.
H.R. 1284, Saving Americas Pollinators Act of 2015.
H.R. 1599, Safe and Accurate Food Labeling Act of 2015.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office, Agriculture - Dept of (USDA), Environmental Protection Agency (EPA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christopher |
Leahy |
|
|
|
Matthew |
Perin |
|
|
|
Donna |
Stephens |
|
|
|
James |
McVaney |
|
|
|
Ursula |
Wojciechowski |
|
|
|
Edward |
Barron |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Monitor legislative and administrative action on appropriations and budget.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christopher |
Leahy |
|
|
|
Brian |
Nagle |
|
|
|
Matthew |
Perin |
|
|
|
James |
McVaney |
|
|
|
Edward |
Barron |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
Monitor legislative and administrative action related to intellectual property protection.
S. 1137, PATENT Act.
H.R. 9, Innovation Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), U.S. Copyright Office
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christopher |
Leahy |
|
|
|
Brian |
Nagle |
|
|
|
Brian |
McCullough |
|
|
|
Julie |
Corcoran |
|
|
|
Edward |
Barron |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Monitor legislative and administrative action related to health care policy.
Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising.
Monitor legislative and administrative action related to the 340B Drug Pricing Program.
Monitor legislative and administrative action related to access to medical supplies.
Monitor legislative and administration action related to womens health issues.
Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program.
Monitor legislative and administrative action related to over-the-counter consumer care products.
Monitor legislative and administrative action related to age restrictions on access to particular drugs.
Monitor activities related to the implementation of the Drug Quality and Security Act (2013).
Monitor legislative and administrative action related to dietary supplements.
H.R. 6, 21st Century Cures Act.
H.R. 771, Protecting Access to Diabetes Supplies Act of 2015.
H.R. 1537, Advancing Hope Act of 2015.
H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christopher |
Leahy |
|
|
|
Donna |
Stephens |
|
|
|
Julie |
Corcoran |
|
|
|
Brian |
McCullough |
|
|
|
Brian |
Nagle |
|
|
|
Hallie |
Utley |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Monitor legislative and administrative action related to Medicare policy.
Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal.
Monitor enforcement of Medicares imaging equipment preventative maintenance policy.
Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment.
S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015.
H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christopher |
Leahy |
|
|
|
Donna |
Stephens |
|
|
|
Julie |
Corcoran |
|
|
|
Brian |
Nagle |
|
|
|
Hallie |
Utley |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAR
16. Specific lobbying issues
Monitor legislative and administrative action related to miscellaneous tariff legislation.
H.R. 644, Trade Facilitation and Trade Enforcement Act of 2015.
H.R. 1907, Trade Facilitation and Trade Enforcement Act of 2015.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christopher |
Leahy |
|
|
|
Brian |
McCullough |
|
|
|
Matthew |
Perin |
|
|
|
Ursula |
Wojciechowski |
|
|
|
Edward |
Barron |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Monitor legislative and federal activity related to tax reform.
H.R. 160, Protect Medical Innovation Act of 2015.
S. 149, Medical Device Access and Innovation Protection Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christopher |
Leahy |
|
|
|
Donna |
Stephens |
|
|
|
Brian |
McCullough |
|
|
|
Ursula |
Wojciechowski |
|
|
|
Hallie |
Utley |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TRD
16. Specific lobbying issues
Monitor legislative issues and administrative action related to trade.
Monitor legislative and administrative action related to trade promotion authority negotiations.
Monitor legislative and administrative action related to Trans-Pacific Partnerships.
Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership.
Monitor legislative and administrative action related to Environmental Goods Agreement.
H.R. 644, Trade Facilitation and Trade Enforcement Act of 2015.
H.R. 1890, Bipartisan Congressional Trade Priorities and Accountability Act of 2015.
H.R. 1891, To extend the African Growth and Opportunity Act, the Generalized System of Preferences, the preferential duty treatment program for Haiti, and for other purposes.
H.R. 1907, Trade Facilitation and Trade Enforcement Act of 2015.
H.R. 2146, Defending Public Safety Employees' Retirement Act (Title 1 -Bipartisan Congressional Trade Priorities and Accountability Act of 2015).
S. 995, Bipartisan Congressional Trade Priorities and Accountability Act of 2015.
S. 998, American Manufacturing Competitiveness Act of 2015.
S. 1009, AGOA Extension and Enhancement Act of 2015.
S. 1015, Enforcing Orders and Reducing Customs Evasion Act of 2015.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, U.S. Trade Representative (USTR), Environmental Protection Agency (EPA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christopher |
Leahy |
|
|
|
Matthew |
Perin |
|
|
|
Brian |
McCullough |
|
|
|
Ursula |
Wojciechowski |
|
|
|
James |
McVaney |
|
|
|
Julie |
Corcoran |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TRA
16. Specific lobbying issues
Monitor legislative and administrative action related to Positive Train Control.
H.R. 3651, Positive Train Control Enforcement and Implementation Act of 2015.
S. 650, Railroad Safety and Positive Train Control Extension Act.
S. 1006, Positive Train Control Safety Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christopher |
Leahy |
|
|
|
James |
McVaney |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |